--2025/Q3-- / 449.901B--
--2025/Q2-- / 422.565B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
US Stock MarketDetailed Quotes
ALPMY Astellas Pharma (ADR)
- 11.445
- +0.065+0.57%
15min DelayTrading Oct 2 13:36 ET
20.48BMarket Cap136.24P/E (TTM)
11.510High11.210Low65.09KVolume11.400Open11.380Pre Close745.10KTurnover0.00%Turnover Ratio173.40P/E (Static)1.79BShares14.03052wk High1.82P/B20.48BFloat Cap9.15052wk Low0.43Dividend TTM1.79BShs Float18.789Historical High3.76%Div YieldTTM2.64%Amplitude0.508Historical Low11.448Avg Price1Lot Size
Astellas Pharma (ADR) Key Stats
Astellas Pharma (ADR) Q1 2025 Earnings Date
Currency：JPYAug 1, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 411.42B | 473.12B | +61.71B |
| Beat Est. | +9.71% | +26.17% | +15.00% |
| EPS | -- | 20.94 | -- |
+13.68% |
Analyst Rating
No Data
Astellas Pharma (ADR) Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data